Latest news with #AndrewKress
Yahoo
18-06-2025
- Health
- Yahoo
Introducing HealthVerity Notes: Verified clinical narratives now available for real-world research and commercial use
HealthVerity Notes adds de-identified, unstructured clinical documentation to expand context and enrich patient journey analysis across life sciences use cases PHILADELPHIA, June 18, 2025 /PRNewswire/ -- HealthVerity, the leader in privacy-protecting technologies and the nation's largest verified healthcare and consumer data ecosystem, today announced the launch of HealthVerity Notes, a modular, de-identified dataset built from over 2.5 billion unstructured clinical EHR notes that employs novel methodologies to preserve the full note. This approach adds vital context to real-world data strategies across life sciences research, commercial pharma and analytics use cases. Building on a commitment to verified, research-ready data, HealthVerity Notes introduces a new dimension of patient understanding by unlocking free-text documentation from clinical encounters including insights from physician observations and symptom descriptions to disease progression and therapeutic response. Delivered with modular access and accurately linked by HealthVerity IDs (HVIDs), HealthVerity Notes is now available as an integral part of the nation's largest data ecosystem. The underlying de-identification technology can also be leveraged by data providers to commercialize a wider range of free-text documents. "With HealthVerity Notes, we're turning the unstructured into the actionable," said Andrew Kress, CEO at HealthVerity. "This launch marks an important new capability in our mission to help life sciences organizations unlock deeper insights from real-world data, while preserving patient privacy and ensuring interoperability across datasets." By preserving the full text of the original clinical documentation, HealthVerity Notes supports downstream use of natural language processing (NLP), offering linguistically intact and context-rich documentation that complements structured claims, EHR, and lab data. Whether identifying undiagnosed symptoms, tracing adverse events, or capturing disease trajectory, HealthVerity Notes enables more complete, narrative-driven analytics. HealthVerity Notes is now available with use cases spanning clinical development, HEOR, pharmacovigilance, commercial analytics and patient journey analysis. To learn more, visit or contact info@ About HealthVerityHealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making. HealthVerity contact: info@ View original content to download multimedia: SOURCE HealthVerity, Inc. Sign in to access your portfolio
Yahoo
05-06-2025
- Business
- Yahoo
HealthVerity and Medeloop Announce Strategic Partnership to Enhance Real-World Evidence Insights with AI-Driven Analytics
PHILADELPHIA and MENLO PARK, Calif., June 5, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange and Medeloop, innovators in AI-powered healthcare analytics, announced today an exclusive partnership designed to simplify and dramatically accelerate how pharmaceutical and biotech organizations, governments, and medical or public health researchers use real-world data for actionable insights and evidence generation. This powerful collaboration unites HealthVerity's extensive, privacy-compliant data ecosystem with Medeloop's cutting-edge AI Agent Analytics technology, enabling customers to uncover insights with unprecedented speed and transform vast, complex datasets into clear, actionable intelligence. Medeloop is a no-code analytics platform where a simple written research question is transformed into a full study, allowing users to rapidly generate insights without requiring programming expertise. Innovative researchers and analytics teams will benefit from unparalleled analytical power, accelerating the speed and impact of their research and decision-making processes. Through this partnership, Medeloop customers across Academic Medical Centers and Health Systems now have access to over 200 million de-identified patient records from HealthVerity's real-world data ecosystem, empowering them to ask their most complex research questions against research grade RWD at scale. Concurrently, HealthVerity pharmaceutical and biotech clients benefit from immediate integration of Medeloop's cutting-edge analytics technology, allowing them to generate deeper, more precise insights tailored specifically to their critical healthcare and research needs. "Our partnership with Medeloop represents a dramatic leap forward in real-world data analytics," said Andrew Kress, CEO of HealthVerity. "Previously, generating insights from real-world data required extensive teams and months of effort. Now, with this partnership combining our access to large-scale real-world data and Medeloop's leading-edge technology, we're enabling researchers and healthcare professionals to directly pose complex questions and receive powerful insights within minutes in a fully transparent, monitored, and human-guided fashion, fundamentally changing the pace and accessibility of data-driven healthcare research." René Caissie, CEO of Medeloop, added: "With HealthVerity, we're reshaping the future of healthcare analytics. By integrating the latest innovations in AI Agent Analytics with the richest real-world datasets available, we empower customers to rapidly achieve insights previously out of reach. This partnership accelerates scientific discovery, drives innovation, and ultimately helps save lives by enabling faster, more informed decisions that improve public health outcomes." Media Contacts: HealthVerityinfo@ MedeloopJohn W. Ayers, Ph.D., About HealthVerity HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making. About Medeloop Medeloop offers advanced, AI-powered analytics platforms designed to simplify and accelerate healthcare research, enabling pharmaceutical companies, healthcare providers, and researchers to rapidly derive actionable insights from complex real-world data by simply asking a question. View original content to download multimedia: SOURCE HealthVerity, Inc.
Yahoo
13-05-2025
- Business
- Yahoo
Premier, Inc. named as data source in HealthVerity Marketplace™ to expand real-world data access for life sciences research
Integration delivers high-value datasets including chargemaster, laboratory results and EMR data to accelerate clinical and commercial insights PHILADELPHIA, May 13, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced the addition of Premier, Inc. (NASDAQ: PINC) to HealthVerity Marketplace™, meaning life sciences organizations using HealthVerity Marketplace™ can now access Premier's high-quality, healthcare data to support research across the product lifecycle. HealthVerity Marketplace is the nation's largest verified healthcare and consumer data ecosystem, offering access to over 340 million de-identified individuals and enabling precise patient journey insights through the HIPAA-compliant linkage of diverse data types. With the addition of Premier data, HealthVerity Marketplace users can now use the platform to discover and license inpatient and outpatient data that supports evidence generation across a wide range of use cases, including market access, clinical development, and epidemiological research. Premier data available through HealthVerity Marketplace includes inpatient and outpatient electronic medical record (EMR) data. This opens pathways for the inclusion of de-identified, unstructured clinical notes. These enhancements will enable researchers to further validate clinical insights and strengthen study design with previously unavailable data. The Premier® Healthcare Database (PHD) is one of the most comprehensive electronic healthcare data repositories and the largest inpatient and outpatient chargemaster database. For nearly 25 years, it has served as a valuable source of RWD for the pharmaceutical and medical device industries, academic institutions, government agencies, and hospitals and health systems. Researchers using the PHD can analyze device and drug utilization with greater specificity, uncover trends in resource use and outcomes, and generate insights into care quality, safety and cost. Premier also offers EMR chart retrieval and review services that support regulatory-grade research and verification needs. "Our sharp focus on differentiated data, leading-edge research and clinical trials innovation helps drive speed to value," said Denise Juliano, Premier Applied Sciences Group Vice President. "Having the right data is critical for life sciences organizations aspiring to create meaningful change in healthcare. "Premier's partnership with HealthVerity securely links Premier® data with other real-world datasets, expanding on its longitudinal view of the patient journey that helps measure the effectiveness, quality and cost of therapies." "We are thrilled to officially welcome Premier as a named partner in HealthVerity Marketplace," said Andrew Kress, CEO of HealthVerity. "Premier's extensive, high-quality data adds substantial value for pharmaceutical manufacturers and healthcare innovators. These precise clinical insights are essential for therapeutic advancements and targeted patient care strategies." About HealthVerity HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making. To learn more, please visit HealthVerity contact:info@ About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, consulting and other services in service of our mission to improve the health of communities. Please visit Premier's news and investor sites on as well as X, Facebook, LinkedIn, YouTube, Instagram and Premier's blog for more information about the company. Premier contact:Public_Relations@ View original content to download multimedia: SOURCE HealthVerity, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
16-04-2025
- Business
- Associated Press
HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, has licensed its real-world data to enhance clinical trial design and analytics. Through this agreement, Recursion will integrate HealthVerity de-identified data for over 340M covered lives within the US into its advanced data science and machine learning platforms, the Recursion OS, allowing for deeper insights into patient populations, enhanced trial design and feasibility assessments, as well as clinical operations workflows. By leveraging these high-quality, linked data assets, Recursion seeks to industrialize clinical development, reduce costs, and accelerate the development of novel therapeutics. 'Our partnership with Recursion underscores the transformative potential of real-world data in driving smarter clinical trials,' said Andrew Kress, CEO of HealthVerity. 'By providing seamless access to the industry's most comprehensive and interoperable real-world data, we empower innovators like Recursion to make data-driven decisions that streamline clinical development.' Recursion's proprietary AI-driven approach relies on integrating diverse datasets and AI/ML models to identify novel insights into human biology and molecule design. The incorporation of real-world data from HealthVerity Marketplace will further strengthen Recursion's ability to predict patient responses, refine study designs, and ensure clinical trial sites are positioned to meet enrollment goals. 'With the majority of the industry's time and resources focused on clinical trials, we see a significant opportunity to transform how clinical development is designed and executed,' said Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. 'By integrating privacy-compliant real-world data from HealthVerity into Recursion OS, we are advancing our mission to optimize trial design through in silico simulations, accelerate recruitment through a patient-centric approach that includes underserved populations, and generate stronger evidence to inform development and regulatory decisions. By doing so, we are not only streamlining clinical development but also ensuring that we bring more impactful, life-changing treatments to patients faster and more efficiently' The HealthVerity approach to real-world data acquisition and governance ensures compliance with HIPAA and other regulatory frameworks while maintaining the highest standards of patient privacy. By combining data from the nation's largest healthcare data ecosystem, HealthVerity enables precise patient journey insights, supporting clinical development, regulatory submissions, and post-market studies. For more information, visit About HealthVerity HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making. About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine. Media Contact: HealthVerity [email protected] Recursion [email protected] View original content to download multimedia: SOURCE HealthVerity, Inc.
